Saddle Brook, New Jersey Clinical Trials

A listing of Saddle Brook, New Jersey clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 74 clinical trials
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen
migraine
lasmiditan
headache
ly573144
Columbia University
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +162 other locations
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Primary Objective: To confirm appropriate dose levels of fitusiran when administered to male pediatric participants (ages 1 to <12 years of age) with severe hemophilia A or B Secondary Objective: To characterize the safety and tolerability To characterize the pharmacokinetics (PK)

bethesda assay
severe haemophilia a
antihemophilic factor
fitusiran
haemophilia a
Investigational Site Number 8400008
 (2.7 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +10 other locations
Asthma 2  

Asthma 2

P Site 2
 (9.7 away)
  • 0 views
  • 16 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Columbia University Irving Medical Center / NYPH
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

systemic therapy
ros1
measurable disease
LKB1
vitamin b12 level
New Jersey Cancer Care and Blood Disorders (NJCCBD)
 (8.2 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +27 other locations
CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas

The blood brain barrier (BBB) prevents some drugs from successfully reaching the target source. Convection-Enhanced Delivery (CED) is a method of direct infusion of drugs under controlled pressure to the tumor that may reduce systemic side effects of drugs in the patient. The purpose of this Phase I study is …

platelet count
coagulation disorder
anesthesia
dipg
side effects of drugs
Columbia University Irving Medical Center
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) Expression

Non-Small Cell Lung Cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues of the lung. It is the most common form of lung cancer, accounting for around 85% of lung cancers. The purpose of this study is to evaluate the safety and efficacy …

drug test
solid tumor
measurable disease
cancer
venetoclax
Hackensack Univ Med Ctr /ID# 216484
 (2.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +38 other locations
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial

This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …

pegfilgrastim
bone marrow procedure
cancer
blood count
antineoplastic
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
 (8.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +82 other locations
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by …

acupuncture
high dose chemotherapy
cancer
pain management
stem cell transplantation
Hackensack Meridian Health
 (2.7 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
Double-Blind Multicenter Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

This clinical trial will examine if a new treatment of Mesenchymal Stems Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.

acute respiratory distress
respiratory distress
SARS
acute respiratory syndrome (sars)
covid-19
Holy Medical Center
 (4.4 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations